QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Rünker, A. E. Articles by Schachner, M. Search for Related Content PubMed PubMed Citation Articles by Rünker, A. E. Articles by Schachner, M.

 Previous Article  |  Next Article 

The Journal of Neuroscience, January 1, 2003, 23(1):277-286

The C264Y Missense Mutation in the Extracellular Domain of L1 Impairs Protein Trafficking In Vitro and In Vivo

Annette E. Rünker¹, Udo Bartsch¹, Klaus-Armin Nave², and Melitta Schachner¹

¹ Zentrum für Molekulare Neurobiologie, Universität Hamburg, D-20246 Hamburg, Germany, and ² Department of Neurogenetics, Max-Planck-Institute for Experimental Medicine, D-37075 Göttingen, Germany

The neural cell adhesion molecule L1, a member of the immunoglobulin superfamily, performs important functions in the developing and adult nervous system and is implicated in neuronal migration and survival, elongation, fasciculation and pathfinding of axons, and synaptic plasticity. This view is in line with the fact that mutations in the L1 gene result in severe neurological syndromes in humans. Patients with missense mutations in the extracellular domain of L1 often develop severe phenotypes. Here, we characterized in vitro and in vivo the missense mutation C264Y, which is located in the extracellular domain of L1 and causes a severe phenotype in humans. Transfection studies in vitro demonstrate that L1 carrying this missense mutation is not expressed at the cell surface but instead is located intracellularly, most likely within the endoplasmic reticulum. Lack of cell surface expression of L1 with a C264Y mutation was confirmed in a transgenic mouse line expressing the C264Y mutation under the control of the L1 promoter in an L1-deficient background. Analysis of these transgenic mice indicates that they represent functional null mutants, phenotypically indistinguishable from L1-deficient mice. These observations corroborate the view that impaired cell surface expression of mutated variants of L1 is a potential explanation for the high number of severe pathogenic mutations identified within the human L1 gene.

Key words: L1; missense mutation; protein trafficking; transgenic mouse; human disease; adhesion molecule

---

Copyright © 2003 Society for Neuroscience  0270-6474/03/231277-10$05.00/0

This article has been cited by other articles:

				K. Nagaraj, L. V. Kristiansen, A. Skrzynski, C. Castiella, L. Garcia-Alonso, and M. Hortsch Pathogenic human L1-CAM mutations reduce the adhesion-dependent activation of EGFR Hum. Mol. Genet., October 15, 2009; 18(20): 3822 - 3831. [Abstract] [Full Text] [PDF]

				K. Knogler, J. Grunberg, K. Zimmermann, S. Cohrs, M. Honer, S. Ametamey, P. Altevogt, M. Fogel, P. A. Schubiger, and I. Novak-Hofer Copper-67 Radioimmunotherapy and Growth Inhibition by Anti-L1-Cell Adhesion Molecule Monoclonal Antibodies in a Therapy Model of Ovarian Cancer Metastasis Clin. Cancer Res., January 15, 2007; 13(2): 603 - 611. [Abstract] [Full Text] [PDF]

				K. Itoh, L. Cheng, Y. Kamei, S. Fushiki, H. Kamiguchi, P. Gutwein, A. Stoeck, B. Arnold, P. Altevogt, and V. Lemmon Brain development in mice lacking L1-L1 homophilic adhesion J. Cell Biol., April 12, 2004; 165(1): 145 - 154. [Abstract] [Full Text] [PDF]

				C. Belville, H. Van Vlijmen, C. Ehrenfels, B. Pepinsky, A. R. Rezaie, J.-Y. Picard, N. Josso, N. d. Clemente, and R. L. Cate Mutations of the Anti-Mullerian Hormone Gene in Patients with Persistent Mullerian Duct Syndrome: Biosynthesis, Secretion, and Processing of the Abnormal Proteins and Analysis Using a Three-Dimensional Model Mol. Endocrinol., March 1, 2004; 18(3): 708 - 721. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help